Heat-Shock Protein 90 Controls the Expression of Cell-Cycle Genes by Stabilizing Metazoan-Specific Host-Cell Factor HCFC1
Aneliya Antonova,
Barbara Hummel,
Ashkan Khavaran,
Desiree M. Redhaber,
Fernando Aprile-Garcia,
Prashant Rawat,
Kathrin Gundel,
Megan Schneck,
Erik C. Hansen,
Jan Mitschke,
Gerhard Mittler,
Cornelius Miething,
Ritwick Sawarkar
Affiliations
Aneliya Antonova
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany
Barbara Hummel
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Ashkan Khavaran
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany
Desiree M. Redhaber
German Consortium for Translational Cancer Research (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany
Fernando Aprile-Garcia
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Prashant Rawat
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany
Kathrin Gundel
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Megan Schneck
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Erik C. Hansen
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Jan Mitschke
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany
Gerhard Mittler
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Cornelius Miething
German Consortium for Translational Cancer Research (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany
Ritwick Sawarkar
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany; MRC Toxicology Unit, University of Cambridge, Cambridge, UK; Corresponding author
Summary: Molecular chaperones such as heat-shock proteins (HSPs) help in protein folding. Their function in the cytosol has been well studied. Notably, chaperones are also present in the nucleus, a compartment where proteins enter after completing de novo folding in the cytosol, and this raises an important question about chaperone function in the nucleus. We performed a systematic analysis of the nuclear pool of heat-shock protein 90. Three orthogonal and independent analyses led us to the core functional interactome of HSP90. Computational and biochemical analyses identify host cell factor C1 (HCFC1) as a transcriptional regulator that depends on HSP90 for its stability. HSP90 was required to maintain the expression of HCFC1-targeted cell-cycle genes. The regulatory nexus between HSP90 and the HCFC1 module identified in this study sheds light on the relevance of chaperones in the transcription of cell-cycle genes. Our study also suggests a therapeutic avenue of combining chaperone and transcription inhibitors for cancer treatment. : What do chaperones do in the nucleus? Antonova et al. perform a comprehensive genetic and physical interactome analysis of nuclear HSP90 in human cells. HSP90 stabilizes the HCFC1 complex at chromatin, contributing to the expression of HCFC1-targeted cell-cycle genes. The simultaneous inhibition of HSP90 and transcription is synergistic in killing cancer cells. Keywords: chaperone, HSP90, HCFC1, chromatin, cancer, synergistic inhibition